IDEXX Laboratories Inc. closed 27.51% short of its 52-week high of $583.39, which the company reached on March 1st.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...

Shares of IDEXX Laboratories Inc. IDXX shed 0.94% to $418.63 Tuesday, on what proved to be an all-around positive trading ...

Signal Advisors Wealth LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 25.7% in the fourth ...

ST Germain D J Co. Inc. grew its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 517.2% in the 4th quarter, ...

IDEXX’s IDXX business continues to be dampened by currency impacts and uncertain macroeconomic conditions. The stock carries ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Synopsys, Inc. Named Outstanding Leader, Nell Triplett of Juniper Networks Awarded Outstanding Executive, and IDEXX Laboratories, Inc. Recognized as Breakthrough Corporate LeaderBOSTON ...